Back
ANI Pharmaceuticals Quote, Financials, Valuation and Earnings
Free, 30-minute video on trading overnight options for big gains
Get access to this 30-minute training free here.
Buy
55
ANIP
ANI Pharmaceuticals
Last Price:
61.43
Seasonality Move:
-3.21%
7 Day Trial
ALL ACCESS PASS
$
7
Watch this free video on trading overnight options
Get the free overnight options training here.ANI Pharmaceuticals Price Quote
$61.43
-0.01 (1%)
(Updated: July 6, 2024 at 5:38 AM ET)
ANI Pharmaceuticals Key Stats
Buy
55
ANI Pharmaceuticals (ANIP)
is a Buy
Day range:
$60.56 - $61.57
52-week range:
$48.20 - $70.81
Dividend yield:
0%
P/E ratio:
72.28
P/S ratio:
2.25
P/B ratio:
2.85%
Volume:
129.3K
Avg. volume:
179.3K
1-year change:
14.93%
Market cap:
$1.3B
Revenue:
$486.8M
EPS:
$1.58
How Much Does ANI Pharmaceuticals Make?
-
How Much Are ANI Pharmaceuticals's Sales Annually?
ANIP Revenues are $486.8M -
How Much Profit Does ANI Pharmaceuticals's Make A Year?
ANIP net income is $18.8M
Is ANI Pharmaceuticals Growing As A Company?
-
What Is ANI Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.29% -
What Is ANI Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 12.67%
ANI Pharmaceuticals Stock Price Performance
-
Did ANI Pharmaceuticals Stock Go Up Last Month?
ANI Pharmaceuticals share price went down by -8.3% last month -
Did ANIP's Share Price Rise Over The Last Year?
ANIP share price rose by 14.93% over the past 1 year
What Is ANI Pharmaceuticals 52-Week High & Low?
-
What Is ANI Pharmaceuticals’s 52-Week High Share Price?
ANI Pharmaceuticals has traded as high as $70.81 over the past 52 weeks -
What Is ANI Pharmaceuticals’s 52-Week Low Share Price?
ANI Pharmaceuticals has traded as low as $48.20 over the past 52 weeks
ANI Pharmaceuticals Price To Free Cash Flow
-
Is ANI Pharmaceuticals Stock Overvalued?
ANI Pharmaceuticals is trading at a price to free cash flow ratio of 12.23 -
Is ANI Pharmaceuticals Stock Undervalued?
ANI Pharmaceuticals EV to Free Cash Flow ratio is 14.31 -
What Is ANI Pharmaceuticals’s Price Earnings Growth Ratio?
ANIP PEG ratio is 0.00 -
Is ANI Pharmaceuticals Trading At A Premium To Earnings?
ANI Pharmaceuticals EV to EBIT ratio is 20.33
Is It Risky To Buy ANI Pharmaceuticals?
-
How Much Debt Does ANI Pharmaceuticals Have?
Total long term debt quarterly is $285.5M -
How Much Cash Does ANI Pharmaceuticals Have?
Cash and short term investments quarterly total is $238.3M -
What Is ANI Pharmaceuticals’s Book Value Per Share?
Book value per share is 21.54
Is ANI Pharmaceuticals Cash Flow Positive?
-
What Is ANIP Cash Flow From Operations?
Cash flow from operations (TTM) is $115.8M -
What Is ANI Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $52.3M -
What Is ANI Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$7.2M
ANI Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
ANIP return on invested capital is 4.95% -
What Is ANI Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 4.1% -
What Is ANIP Return On Equity?
ROE is a measure of profitability and is 8.22%
ANI Pharmaceuticals Earnings Date & Stock Price
-
What Is ANI Pharmaceuticals's Stock Price Today?
A single share of ANIP can be purchased today for 61.44 -
What Is ANI Pharmaceuticals’s Stock Symbol?
ANI Pharmaceuticals trades on the nasdaq under the ticker symbol: ANIP -
When Is ANI Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for ANI Pharmaceuticals is scheduled on August 9, 2024 -
When Is ANIP's next ex-dividend date?
ANI Pharmaceuticals's next ex-dividend date is July 8, 2024 -
How To Buy ANI Pharmaceuticals Stock?
You can buy ANI Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ANI Pharmaceuticals Competitors
-
Who Are ANI Pharmaceuticals's Competitors?
Below is a list of companies who compete with ANI Pharmaceuticals or are related in some way:
ANI Pharmaceuticals Dividend Yield
Data Unavailable
ANI Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 1266.67% | 21.49% |
| Revenue: | 28.7% | 9.05% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 83.00 |
| Upside from Last Price: | 35.09% |